Underwriting disclosures
Vaping, Nicotine Pouches and Cannabis on a Life Insurance Application
Underwriting and health · Updated October 28, 2026
Answer every nicotine and cannabis question on a life insurance application exactly as the form frames it, with dates, because some applications include a lab test that looks for nicotine and others do not, the insurer can check your answers either way (the NAIC Buyer's Guide: "The insurance company will check your answers"), and a wrong answer can cost the claim later. Whether an insurer treats vaping, a nicotine pouch or cannabis the same as cigarettes is the insurer's own rule, and we found no regulator that publishes a standard for it. So the safe order is to ask the agent how that insurer classifies your product, get the answer in writing, and then apply.
This page covers the parts that can be sourced: what these products contain, what the common nicotine test measures, how misstatement rules work, and how to prepare a clean disclosure. It does not claim to know how any insurer will classify any product, and it does not predict a price or a class for any reader. For the pricing side of tobacco status, see smoker versus non-smoker pricing.
Sources and dates: how we check each figure.
Why this question has no single answer
A reader searching for "does vaping count as smoking for life insurance" usually wants a yes or no. Brokers and lead-generation sites supply one, and often a precise-sounding abstinence period or test cutoff. We looked for a regulator, a state insurance department or an actuarial body that publishes the rule, and did not find one. Each insurer sets its own underwriting guidelines, and we found none published by a regulator, so nobody outside a company can say what its current guidelines contain. That is why this page does not give you a classification table. Any table would be somebody's guess about a moving target.
What can be stated with confidence comes from agencies that study the products, laboratories that measure nicotine exposure, and insurance statutes that govern what happens after a wrong answer. Those three pieces are enough to build a disclosure routine that works with any insurer. The routine does not depend on how that insurer draws its lines.
What the products contain, according to the agencies
| Product | What a federal agency says | What the application is likely to ask |
|---|---|---|
| E-cigarettes and vapes | The CDC says they typically contain nicotine, that some products marketed as zero-percent nicotine have been found to contain nicotine, and that some devices can deliver cannabis or other drugs. It states the aerosol is not harmless "water vapor" (CDC, About E-Cigarettes, checked October 28, 2026). | Whether you use e-cigarettes or vaping products, how often, and when you last did. Ask the insurer whether the nicotine strength you use changes the answer. Forms differ. |
| Nicotine pouches | The FDA describes them as small synthetic fiber pouches containing nicotine, designed to be placed between the gum and lip. On January 16, 2025 it authorized marketing of 20 ZYN products, and said that does not mean tobacco products are safe (FDA announcement, checked October 28, 2026). | May be asked under a general nicotine or tobacco product question. Ask how this insurer words it, because the question may list products by name. |
| Nicotine replacement (patches, gum, lozenges) | These deliver nicotine, which is why they are used to quit. A review of nicotine pharmacology by Benowitz and colleagues (2009, NIH author manuscript PMC2953858) says cotinine levels produced by replacement therapy are usually 30 to 70 percent of the levels seen while smoking. No federal source we read says how life insurers treat them. | Ask whether current use of a quit aid changes the answer, and whether it is asked separately from tobacco use. |
| Cannabis (smoked, vaped, ingested) | Cannabis is not a nicotine product. The CDC notes that some devices can deliver cannabis. Its federal legal status changed in 2026 and is set out in the section on federal law below. | Some forms ask about marijuana separately from tobacco, and some ask about drug use more broadly. Ask how this insurer words it. |
The third column describes questions to ask, not rules. We cite no insurer for it, because we found no regulator source that does. The point of the table is that the first two columns are public, sourced facts, and the third one is the part that belongs to each insurer.
What the nicotine test reads
Where an application includes a lab test for nicotine, the usual target is cotinine, though we found no regulator source describing insurer testing practice. The best public explanation of the marker we found is a Centers for Disease Control and Prevention laboratory manual used for its national health survey (NHANES Laboratory Procedure Manual, Cotinine and Hydroxycotinine, method 2017, revised June 13, 2016, checked October 28, 2026). It says:
- Cotinine and trans-3'-hydroxycotinine are the primary metabolites of nicotine, and their concentrations in body fluids can be used as markers for active smoking and as indices of secondhand smoke exposure.
- Cotinine is generally regarded as the marker of choice, because the metabolites are present at greater concentrations and clear more slowly than nicotine itself.
- The estimated elimination half-life of cotinine is about 15 to 20 hours. Nicotine's half-life is only 0.5 to 3 hours.
- Cotinine can be measured in serum, urine and saliva, and its half-life is essentially the same in all three. Concentrations tend to be three to eight times higher in urine than in serum.
Three practical points follow, each one a reading of the manual and not a statement about any insurer.
The test reads nicotine exposure, not the product. Cotinine is a metabolite of nicotine, so it does not know whether the nicotine arrived in a cigarette, a vape, a pouch or a patch. A result shows nicotine exposure. How an insurer interprets a result, and what cutoff it applies, is set by the insurer and its laboratory, and the CDC manual does not publish one. Be wary of any source that quotes a single cutoff or a number of days as if it were universal.
A nicotine test does not test for cannabis. Because cotinine is a nicotine metabolite, a product with no nicotine would not produce it. That is a reading of the chemistry. Whether an insurer's exam also includes a drug screen is a separate question to ask. A product that mixes both substances is another reason to read the label and answer for what you actually use.
Time matters, but the number is not ours to give. A half-life of 15 to 20 hours means the amount of cotinine in the body falls by half every 15 to 20 hours after nicotine intake stops, and a test taken days later sees a smaller number than one taken the same day. The example below shows only the arithmetic of halving, to explain why timing is a fair question to ask. It is not a detection window.
For example, with a 20-hour half-life and one dose, about 59.5 percent remains after 15 hours and 12.5 percent after 60 hours; with a 15-hour half-life, 50 percent remains after 15 hours and about 6 percent after 60 hours.
The chart draws the same arithmetic for four days. It is a picture of halving, not of any test: the curves start from whatever level a person had at the last intake and say nothing about where a laboratory draws its line.
Show the values as a table
| Hours after last intake | Remaining, 15-hour half-life | Remaining, 20-hour half-life |
|---|---|---|
| 15 | 50.0% | 59.5% |
| 24 | 33.0% | 43.5% |
| 48 | 10.9% | 18.9% |
| 60 | 6.3% | 12.5% |
| 72 | 3.6% | 8.2% |
| 96 | 1.2% | 3.6% |
The percentages are plain halving arithmetic from the CDC's stated half-life range, assuming one dose and no further intake. Daily users keep topping up, individual metabolism varies, and the CDC manual does not say what level a lab treats as positive. Treat the example as a picture of how fast the signal declines. It does not tell you when, or whether, a test will read negative.
The research literature points the same way. The Benowitz review puts the average cotinine half-life at about 16 hours after someone stops smoking, inside the CDC's range, and says that at that half-life cotinine levels reflect relatively short-term exposure, over the past three to four days. That sentence describes a biomarker in research, not an insurer's cutoff. The same review makes a point that matters more for applicants: cotinine indicates exposure to nicotine, and when someone is using nicotine replacement it cannot by itself separate the medicine from tobacco, which is why researchers turn to minor tobacco alkaloids in that case. On this marker, pouches look much the same. A 2026 study of adult nicotine pouch users in the federal PATH survey (Nicotine & Tobacco Research, volume 28, issue 2; PubMed 40923918) found that exclusive pouch users had nicotine metabolite levels comparable to those of exclusive cigarette smokers. A pouch, a patch and a cigarette can all leave the same marker.
The costly mistake is the wrong answer, not the right one
People sometimes treat the nicotine question as a game: shade the answer, hope the test misses it, take the lower rate. The sourced rules show why that fails. The NAIC Life Insurance Buyer's Guide (2026 edition, checked October 28, 2026) says it is important to tell the truth on the application, that the insurance company will check your answers, and that if it discovers false statements after it issues your policy, it could reduce or cancel your coverage.
State law supplies the standards. Washington is one example. Its misrepresentation statute, RCW 48.18.090 (checked October 28, 2026), says that in a written life or disability application, a false statement does not bar recovery unless it was made with actual intent to deceive, or it materially affected either the acceptance of the risk or the hazard assumed by the insurer. Washington also requires life policies to contain a provision making them incontestable after they have been in force during the lifetime of the insured for two years (RCW 48.23.050, checked October 28, 2026), with exceptions the statute lists, such as nonpayment. Wisconsin's regulator summarizes a similar two-year rule in a July 2024 filing checklist. Other states differ in the wording and the exceptions, which is why the contract controls.
Put those pieces together. A nicotine answer is a statement of fact that bears on the risk the insurer accepts. If it is wrong and the death occurs, the insurer can review it, and in the first two years a contest is open. That is the setting that beneficiaries and contestability examines from the claim side. The cost of an honest answer is a different rate class. The cost of a wrong one can be a claim that the family cannot collect. The choice between those two costs is not close, and this site would say so about any application question.
One more practical point. MIB describes itself as a member consortium of life insurers in which applicant information is shared and kept in a coded format (MIB, facts about MIB), and its consumer FAQ says a person would have a file only after applying, in the past seven years, for individually underwritten coverage with a member company where information of underwriting significance was found (MIB FAQ, both checked October 28, 2026). If you apply to more than one insurer, keep the answers consistent. Differences between applications are the kind of thing a records check surfaces.
Federal law, state law and the form
Applicants often assume that a legal product must be a safe answer, or that a product in a legal gray zone can be left off the form. Neither follows, and the federal picture moved twice in the past year, so it is worth setting out exactly where it stood when this page was checked on October 28, 2026.
Marijuana is now split between two schedules. In the Code of Federal Regulations as of October 26, 2026, marihuana is still listed in Schedule I at 21 CFR 1308.11. Since a final rule published April 28, 2026 (91 FR 22714), Schedule III at 21 CFR 1308.13 lists marijuana that is in an FDA-approved product or subject to a state medical marijuana license, along with the matching extract and naturally derived delta-9-THC. The rule's preamble says any other form of marijuana remains a Schedule I controlled substance. The broader proposal to move marijuana to Schedule III, first published May 21, 2024 (89 FR 44597), went back to the DEA, which on the same day noticed a hearing beginning June 29, 2026, citing Executive Order 14370 of December 18, 2025, which directs the Attorney General to complete that rescheduling in the most expeditious manner. As of October 26, 2026 we found no final rule or Administrator decision on the broader proposal in the Federal Register.
Hemp products are about to be redefined. Section 781 of Division B of Public Law 119-37, enacted November 12, 2025, rewrites the federal definition of hemp, effective 365 days after enactment, to count total tetrahydrocannabinols, including THCA, against the 0.3 percent dry-weight limit, and to exclude final products with more than 0.4 milligrams combined of THC and similar cannabinoids per container, as well as cannabinoids that the plant cannot produce or that were synthesized outside it. Public Law 119-103, enacted September 2, 2026, then provided that until December 11, 2026 the amendments apply only to intermediate and final products containing cannabinoids the plant cannot naturally produce. Read together, the two laws mean nothing changes before November 12, 2026; from November 12, only that exclusion applies; and the total-THC and per-container rules apply from December 11, 2026, unless Congress acts again. Check congress.gov for later changes. Executive Order 14370 itself notes that some full-spectrum CBD products will once again be controlled as marijuana when section 781 takes effect, because they exceed the per-container threshold.
CBD can carry THC. The FDA's consumer page on cannabis-derived products says THC is the component that produces the high, that many CBD products it tested did not contain the levels of CBD they claimed, and that it is investigating reports of CBD products containing unsafe levels of contaminants, naming THC among them. An applicant who uses only CBD may still be asked about it under a cannabis or drug question, and may want to know before any drug screen what the product actually contains.
Synthetic nicotine is nicotine. On the tobacco side, the Consolidated Appropriations Act, 2022, signed March 15, 2022, extended the FDA's tobacco product authority to products containing nicotine from any source, which the FDA says includes synthetic nicotine, effective April 14, 2022. A product sold as tobacco-free is not nicotine-free, and a cotinine test does not know the difference.
None of these rules decides an insurance application. A life insurance form asks what you use, how often and when, in its own words; the scheduling of a substance is a question for criminal and regulatory law, not for the underwriter's question. What the federal changes do mean is that the same product can be described differently on a dispensary receipt, a store shelf and an application, so the safe habit is to describe the product by what it is and contains, and let the form's question decide where it belongs.
Five hypothetical applicants
These people are invented to show the process. They are not typical, and the page does not say how any insurer would classify any of them. The right-hand column is the same in every row: say what is true, in the form's terms, and ask in writing how the insurer treats it.
| Applicant (invented) | What to state on the form | What to ask before applying |
|---|---|---|
| Uses a nicotine vape daily | The product, how often, since when, and the date of last use | Does vaping fall under the tobacco question or a separate nicotine question? Does strength matter? |
| Uses nicotine pouches a few times a week | Pouches by name if the form lists them; otherwise under the closest nicotine question, with frequency | Does the form's definition include pouches? What does "occasional" mean in its wording? |
| Uses cannabis edibles and no nicotine | Cannabis use as the form asks for it, which may be a drug question and not a tobacco one | Is cannabis asked about separately? Is there a frequency cutoff? Does medical use change the wording? |
| Using nicotine gum to quit, no tobacco for four months | The date tobacco stopped and the current use of gum, as separate facts | Does current replacement therapy count? How is time since quitting measured? |
| Quit all nicotine eight months ago | The quit date and the previous product, exactly | What documentation is accepted for the quit date? Is a test required? |
No row says "you will qualify" or "you will not." The outcome is the insurer's decision. What you control is the accuracy of the record and the quality of the question you put to the agent.
A disclosure worksheet
Fill this in before you talk to an agent, and keep a copy with your application papers. It takes a few minutes, and it is built to catch the errors described in this guide before they reach a signed form.
- List every nicotine product you have used in the past several years. Name the type: cigarette, cigar, pipe, smokeless tobacco, e-cigarette or vape, nicotine pouch, patch, gum or lozenge. Include products you stopped. Look-back periods vary, so the longer list is the safer one.
- For each, write the pattern. Daily, weekly, occasional, rare. Write the start date, and the date of last use.
- Write the nicotine strength if you know it. The CDC says it is difficult to know which substances e-cigarettes contain, and that some products marketed as zero-percent nicotine have been found to contain nicotine, so write what is on the package and note that it is the label.
- List cannabis separately. Method (smoked, vaped, ingested), frequency, the date of last use, and whether it was medical or adult use under your state's law. Insurance forms are not decided by state legality, so write the facts and let the form's question decide where they belong.
- List any prescription or over-the-counter quit aids you use now or used recently.
- Note any exam or lab date that has been scheduled, and whether the insurer said what the lab will test for.
- Write the questions for the agent from the right-hand column of the table above, and a line for the answer. Ask for answers by email or in the insurer's own guideline wording. An answer on the phone helps you decide, but one in writing helps you later.
When the application arrives, check each answer against the worksheet rather than from memory. If a question uses a term you do not understand, such as "tobacco products," "nicotine products" or "marijuana," ask what the insurer means by it before you tick a box. Do not read the question more narrowly than it is written.
What to ask the insurer, in order of importance
- How does this insurer define tobacco and nicotine use for rate classes, and does the definition name vaping, pouches and replacement products?
- Is cannabis asked about separately, and if so, how?
- Does frequency change how the use is treated? Is there a cutoff?
- What look-back period applies to each product?
- Does the process include a nicotine test, a drug screen, or both, and when?
- If my test reads differently from my answer, what happens next? Is there a chance to explain?
- If I stop using nicotine after the policy is issued, can the class be reviewed later, and what proof is needed?
- If I am offered a rate class different from the one I applied for, what rights do I have to the reasons?
The last question connects to the denial rights in denied for life insurance. The NAIC model privacy law (Model #670) counts an offer at higher-than-standard rates as an adverse underwriting decision, so the right to ask for the reasons applies to a rated offer as well as an outright decline, according to the model and in states that adopted it.
Before your next application, write the worksheet, send the agent the eight questions above, and compare any rated offer with your other quotes side by side in the term quote comparison tool so that a class difference is not mistaken for a price difference.
Common mistakes
- Searching for a universal rule. There isn't one. Insurers file their own, and the answers differ.
- Trusting a number of days from a broker or lead site. The CDC sets out a half-life range. It does not state an insurer cutoff or a detection window.
- Assuming "only occasionally" means "no." Whether occasional use counts is the insurer's definition. Ask.
- Reading the cannabis question as a question about legality. The form asks what it asks.
- Answering from memory. Use the worksheet.
- Applying to several insurers with different answers. Inconsistent applications can be seen through shared records.
- Assuming the exam is the only check. Application answers and records are checked too.
Where this fits with exams and no-exam policies
Not every policy has a lab test. The route you take changes how a nicotine answer is checked. The NAIC Buyer's Guide says that, depending on the type of policy, the insurer may require a doctor visit, health questions or a home visit from a medical professional. Where there is no lab sample, the application answers and the records checks described above carry the whole weight. Our guide to exam versus no-exam policies explains the tradeoffs of each route, and underwriting questions asked explains how application answers, MIB and prescription history are cross-checked. The honest answer is the same on every route, and the application is still signed and still part of the contract.
Secondhand exposure and other awkward cases
The CDC manual says cotinine is used both as a marker of active smoking and as an index of secondhand smoke exposure. That is a research fact, not a rule for insurers. The practical meaning for an applicant is limited: a lab number does not tell the story of how nicotine reached the body, and the insurer, not this site, decides how a result is read. If you live with a smoker, or work somewhere with heavy exposure, you can mention it to the agent as a fact to ask about, but there is no reason to describe yourself as a user on the form.
Another awkward case is the person who has quit but used a replacement product recently. The honest framing is two separate facts, the date tobacco use ended and the current or recent use of the replacement, and the form's wording decides which question each belongs to. A third is the person whose use changes between the application and the exam. If your use changes after you apply, such as quitting entirely or starting again, tell the agent. A policy is a long contract, and a mismatch found at a record check is easier to explain than one found at a claim.
Reading the form's wording before you answer
Application questions are drafted by the insurer's lawyers, and small words change the meaning. Read each nicotine or cannabis question twice and underline four things before you answer.
- The verb. "Have you used," "do you currently use" and "have you ever used" are three different questions. The first and third reach back in time, and the second does not.
- The time window. "In the past 12 months" and "in the past five years" produce different answers for the same person. The window is stated in the question, and the honest answer is the one that fits it.
- The product list. Some questions list products by name and some use a general phrase. If a list ends with "or any other nicotine or tobacco product," a product you do not see named may still be covered. If you cannot tell, ask the agent whether the product belongs under the question and get the reply in writing.
- The qualifiers. Words such as "regularly," "occasionally," "social" or "recreational" may appear, with or without a definition. Where there is no definition, ask for one rather than choosing your own.
The NAIC Buyer's Guide advises reviewing the application before you sign because the insurance company will check your answers. That includes the pages you did not write yourself. If an agent types your answers into an electronic form, ask to read the whole form on screen or on paper before you sign, and correct anything that is not what you said. The signature, not the conversation, is what the insurer relies on.
A preparation timeline that avoids last-minute surprises
Rushing is where avoidable errors creep in. A calm sequence looks like this, and none of the steps depends on a rule that varies by insurer.
- Several weeks before applying: write the worksheet, and send the written questions to the agent. If you are still using nicotine and are working on quitting, note your quit date accurately, because that date may be asked for and may be checked.
- Before choosing an insurer: compare the answers you received. Different insurers may word the same question differently, and a quote based on your honest answers is the only quote that means anything. Never compare an advertised best-case price with a quote that reflects your real answers.
- At the application: read the form, check each answer against the worksheet, and confirm what the exam or lab step will involve and when it will occur.
- Between application and decision: if anything about your use changes, tell the agent. Respond to the insurer's follow-up requests promptly, with dates.
- At the offer: read the class and the reasons. If the offer is in a nicotine class, ask for the reasons (in states that follow the NAIC privacy model you have a right to them), and put the offer next to quotes at the same amount and term from other insurers.
- After the policy is issued: use the free look window to read the policy, check the answers recorded about you once more, and report any error immediately. The NAIC says the review period is usually 10 days after you receive the policy.
None of this makes the insurer's decision for you. It makes sure that the decision the insurer reaches is based on a record that you can stand behind years later, which is when a record matters most. A family cannot repair an application after a death, and an honest paper trail is the best thing a policyholder can leave.
Education only. TrueLifeCost does not sell insurance, does not predict how any insurer will classify a product, and does not quote prices. The CDC and FDA material is cited for what the products contain and what the lab test measures, not for insurer rules. A licensed agent in your state and the insurer's own guidelines answer the classification question.
Vaping, pouches and cannabis: common questions
Does vaping count as smoking for life insurance?
We found no regulator that publishes a standard, so it depends on the insurer's own underwriting guidelines and the exact wording of its application. The CDC says e-cigarettes typically contain nicotine, and nicotine is what a cotinine test measures, so answer the question as the form is worded and ask the agent in writing how that insurer classifies vaping before you apply.
Do nicotine pouches show up on a life insurance nicotine test?
A cotinine test measures a metabolite of nicotine, and the FDA describes nicotine pouches as containing nicotine, so nicotine from a pouch is the same substance the test is built to detect. The CDC manual does not say what level a laboratory treats as positive. How an insurer classifies pouch use is the insurer's decision, so ask.
Will marijuana use affect my life insurance application?
Some applications ask about cannabis or drug use, but the wording and what follows from an answer vary by insurer, and we found no regulator source that sets a rule. A nicotine test does not measure cannabis. Whether an exam includes a drug screen is something to ask. Answer the form as written, with dates, and let the underwriter classify it.
How long does nicotine stay detectable for a life insurance test?
No official source gives a universal figure for insurance testing. The CDC reports a cotinine half-life of about 15 to 20 hours, which means the amount in the body halves in that time after intake stops, but daily use, metabolism and the laboratory's cutoff all change what a test shows. Sources that quote a fixed number of days are giving estimates.
What happens if I say I don't use nicotine and the test disagrees?
The insurer can review the mismatch. The NAIC Buyer's Guide says the insurer checks your answers and that false statements discovered after a policy is issued could reduce or cancel coverage. State law sets standards, for example Washington requires a false life insurance application statement to be made with actual intent to deceive or to have materially affected the risk accepted. Answering accurately avoids the dispute.
Can I get reclassified after I stop using nicotine?
That is a contract and insurer question. Some insurers review the class after proof of time without nicotine, and some do not, and no regulator source sets a period. Ask before you buy whether a review is possible, what proof is accepted, and whether it applies to your policy type. Keep a record of your quit date.
Do I have to tell the insurer about nicotine replacement like gum or patches?
Answer the question as it is written. Some forms ask about current use of any nicotine product, and replacement products contain nicotine, but we found no source that says how insurers handle them. Write the date tobacco use ended and the current use of the replacement as two separate facts, and ask the agent how the form should treat each.